Jan 07, 09
|
| NEW STORY |
| 07:30 ET |
MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009
|
 |
Dec 04, 08
|
| 16:30 ET |
Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas
|
|
Nov 19, 08
|
| 07:30 ET |
MiddleBrook Pharmaceuticals Hires Key Commercial Team Members
|
|
Nov 13, 08
|
| 06:30 ET |
MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
|
|
Nov 06, 08
|
| 16:30 ET |
MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents
|
|
Nov 03, 08
|
| 07:30 ET |
MiddleBrook Pharmaceuticals Retains National Account Firm VCG & Associates
|
|
Oct 30, 08
|
| 07:30 ET |
MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for Third Quarter 2008 Financial Results
|
|
Oct 22, 08
|
| 07:30 ET |
MiddleBrook Hires TalenTactics to Recruit National Field Force
|
|
Oct 17, 08
|
| 17:00 ET |
Lord James Blyth Appointed Vice Chairman of MiddleBrook
|
|
Oct 14, 08
|
| 07:30 ET |
MiddleBrook to Webcast Management Presentation at the 10th Annual Rodman & Renshaw Healthcare Conference
|
|
Oct 07, 08
|
| 08:00 ET |
MiddleBrook Pharmaceuticals Announces Changes to Management Team
|
|
Sep 04, 08
|
| 16:00 ET |
MiddleBrook Pharmaceuticals Announces Stockholder Approval and Closing of $100 Million Financing Transaction with Equity Group Investments
|
|
Aug 14, 08
|
| 12:01 ET |
MiddleBrook Pharmaceuticals Reports Second Quarter 2008 Results
|
|
Jul 30, 08
|
| 07:37 ET |
MiddleBrook Pharmaceuticals Files Definitive Proxy Statement with Respect to Proposed $100 Million Investment from EGI
|
|
Jul 22, 08
|
| 09:35 ET |
MiddleBrook Pharmaceuticals to Conduct Investor Update Conference Call on July 24, 2008
|
|
Jul 01, 08
|
| 23:03 ET |
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
|
|
May 13, 08
|
| 16:15 ET |
MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
|
|
Mar 14, 08
|
| 08:00 ET |
MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
|
|
Mar 04, 08
|
| 06:55 ET |
MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
|
|
Feb 29, 08
|
| 08:00 ET |
MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
|
|
Feb 14, 08
|
| 06:50 ET |
MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
|
|
Feb 05, 08
|
| 12:07 ET |
MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
|
|
Jan 30, 08
|
| 12:35 ET |
MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
|
|
Jan 25, 08
|
| 06:55 ET |
MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
|
|
Jan 24, 08
|
| 06:45 ET |
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
|
|
Nov 14, 07
|
| 06:50 ET |
MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
|
|
Nov 08, 07
|
| 06:45 ET |
MiddleBrook Pharmaceuticals Reschedules Announcement of its Third Quarter 2007 Financial Results to November 14, 2007
|
|
Nov 07, 07
|
| 16:28 ET |
MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
|
|
Nov 06, 07
|
| 15:14 ET |
MiddleBrook Pharmaceuticals to Announce Third Quarter 2007 Financial Results on November 9, 2007
|
|
Aug 02, 07
|
| 06:50 ET |
MiddleBrook Pharmaceuticals Reports Second Quarter 2007 Results
|
|
Jul 27, 07
|
| 11:08 ET |
MiddleBrook Pharmaceuticals to Announce Second Quarter 2007 Financial Results on August 2, 2007
|
|
Jun 28, 07
|
| 07:00 ET |
Advancis Pharmaceutical Changes Its Name to MiddleBrook Pharmaceuticals, Inc.
|
|
Jun 26, 07
|
| 13:38 ET |
Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design
|
|
May 22, 07
|
| 06:55 ET |
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
|
|
May 08, 07
|
| 07:00 ET |
Advancis Pharmaceutical Reports First Quarter 2007 Results
|
|
May 03, 07
|
| 08:00 ET |
Advancis Pharmaceutical to Announce First Quarter 2007 Financial Results on May 8, 2007
|
|
Apr 23, 07
|
| 14:48 ET |
Advancis Pharmaceutical Appoints New Board Member
|
|
Apr 18, 07
|
| 15:03 ET |
Advancis Pharmaceutical Closes Private Placement of Common Equity Raising $24 Million
|
|
Apr 09, 07
|
| 15:52 ET |
Advancis Pharmaceutical to Raise $24 Million Through Private Placement of Common Equity
|
|
Mar 27, 07
|
| 16:30 ET |
Advancis Pharmaceutical Reports Full Year 2006 Results and 2007 Corporate Initiatives
|
|
Mar 23, 07
|
| 11:44 ET |
Advancis Pharmaceutical Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
|
|
Feb 28, 07
|
| 06:45 ET |
Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDA
|
|
Feb 13, 07
|
| 20:15 ET |
Advancis Pharmaceutical Announces FDA Decision That its Amoxicillin PULSYS NDA is Not Complete
|
|
Jan 12, 07
|
| 07:00 ET |
Advancis Pharmaceutical Announces Preliminary 2006 Product Sales and Year-End Cash Position
|
|
Dec 15, 06
|
| 07:00 ET |
Advancis Pharmaceutical Files New Drug Application For Once-Daily Amoxicillin PULSYS
|
|
Dec 14, 06
|
| 17:42 ET |
Advancis Pharmaceutical Closes Private Placement of Common Equity
|
|
Dec 11, 06
|
| 08:45 ET |
Advancis Pharmaceutical to Raise $18 Million Through Private Placement of Common Equity
|
|
Nov 02, 06
|
| 09:20 ET |
Advancis Pharmaceutical to Present at Rodman and Renshaw 8th Annual Healthcare Conference
|
|
Nov 01, 06
|
| 07:00 ET |
Advancis Pharmaceutical Reports Third Quarter 2006 Results
|
|
Oct 31, 06
|
| 07:15 ET |
Advancis Pharmaceutical Submits Proposed Order in Corporate Name Infringement Lawsuit
|
|
Oct 26, 06
|
| 08:00 ET |
Advancis Pharmaceutical to Announce Third Quarter 2006 Financial Results on November 1, 2006
|
|
Oct 23, 06
|
| 19:37 ET |
Advancis Pharmaceutical Announces Promotion of Robert Bannon to Vice President, Investor Relations & Corporate Communications
|
|
| 16:43 ET |
Advancis Pharmaceutical Announces Promotion of Robert C. Low to Chief Financial Officer
|
|
Oct 13, 06
|
| 07:05 ET |
Advancis Pharmaceutical Provides Update on Keflex Launch
|
|
Sep 28, 06
|
| 10:03 ET |
Advancis Pharmaceutical Receives Judgment in Trademark Infringement Lawsuit
|
|
Sep 13, 06
|
| 07:10 ET |
Advancis Pharmaceutical On Track to File NDA for Amoxicillin PULSYS
|
|
Sep 01, 06
|
| 10:26 ET |
Advancis Pharmaceutical to Present at Thomas Weisel Partners Healthcare Conference
|
|
Aug 10, 06
|
| 12:25 ET |
Advancis Pharmaceutical Announces Positive Results for Amoxicillin PULSYS Phase III Trial
|
|
Aug 02, 06
|
| 07:00 ET |
Advancis Pharmaceutical Reports Second Quarter 2006 Results
|
|
Jul 26, 06
|
| 09:14 ET |
Advancis Pharmaceutical to Announce Second Quarter 2006 Financial Results on August 2, 2006
|
|
Jul 25, 06
|
| 07:00 ET |
Advancis Pharmaceutical Announces Launch of Keflex 750mg Capsules
|
|
Jul 06, 06
|
| 07:00 ET |
Advancis Pharmaceutical Completes $12 Million Credit Facility
|
|
Jun 22, 06
|
| 07:00 ET |
Advancis Pharmaceutical Signs Contract Sales Agreement With Innovex
|
|
Jun 06, 06
|
| 16:15 ET |
Advancis Pharmaceutical to Present at Pacific Growth Equities Life Sciences Growth Conference
|
|
Jun 01, 06
|
| 07:00 ET |
Advancis Pharmaceutical Completes Enrollment in Amoxicillin PULSYS Phase III Trial
|
|
May 15, 06
|
| 07:00 ET |
Advancis Pharmaceutical Receives FDA Approval Letter for New Strengths of Keflex
|
|
May 10, 06
|
| 08:00 ET |
Advancis Pharmaceutical to Present at Rodman and Renshaw Global Healthcare Conference
|
|
May 02, 06
|
| 07:00 ET |
Advancis Pharmaceutical Reports First Quarter 2006 Results
|
|
Apr 26, 06
|
| 14:43 ET |
Advancis Pharmaceutical to Announce First Quarter 2006 Financial Results on May 2, 2006
|
|
Apr 21, 06
|
| 07:00 ET |
Advancis Pharmaceutical Provides Update on Additional Keflex Products
|
|
Mar 06, 06
|
| 14:38 ET |
Advancis Pharmaceutical to Present at Lehman Brothers Global Healthcare Conference
|
|
Feb 28, 06
|
| 07:30 ET |
Advancis Pharmaceutical Strengthens Sales and Marketing Capability With Addition of Key Personnel
|
|
Feb 09, 06
|
| 07:01 ET |
Advancis Pharmaceutical Reports Fourth Quarter and Full Year 2005 Results
|
|
Feb 03, 06
|
| 12:29 ET |
Advancis Pharmaceutical to Announce Fourth Quarter and Full Year 2005 Financial Results on February 9, 2006
|
|
| 07:30 ET |
Advancis Pharmaceutical Appoints R. Gordon Douglas, M.D. Chairman of the Board
|
|
Jan 05, 06
|
| 07:01 ET |
Advancis Pharmaceutical Provides Update on Keflex Brand
|
|
Dec 07, 05
|
| 07:45 ET |
Advancis Pharmaceutical to Present at NYSSA Biotech/Specialty Pharma Conference
|
|
Nov 11, 05
|
| 07:33 ET |
Advancis Pharmaceutical Begins Pivotal Amoxicillin PULSYS Phase III Trial
|
|
Nov 03, 05
|
| 07:01 ET |
Advancis Pharmaceutical to Begin Amoxicillin PULSYS Phase III Trial
|
|
Oct 27, 05
|
| 07:13 ET |
Advancis Pharmaceutical Reports Third Quarter 2005 Results
|
|
Oct 24, 05
|
| 16:15 ET |
Advancis Pharmaceutical Announces Resignation of Steven Shallcross
|
|
Oct 21, 05
|
| 15:21 ET |
Advancis Pharmaceutical to Announce Third Quarter 2005 Financial Results on October 27, 2005
|
|
Sep 15, 05
|
| 07:01 ET |
Advancis Pharmaceutical to Conduct Additional Adult Amoxicillin PULSYS Phase III Trial
|
|
Sep 08, 05
|
| 16:15 ET |
Advancis Pharmaceutical Announces Organizational Change
|
|
Aug 22, 05
|
| 16:23 ET |
Advancis Pharmaceutical Announces Change to Board of Directors
|
|
Aug 04, 05
|
| 07:03 ET |
Advancis Pharmaceutical Reports Second Quarter 2005 Results
|
|
Aug 01, 05
|
| 17:03 ET |
Advancis Pharmaceutical to Announce Second Quarter 2005 Financial Results on August 4, 2005
|
|
Jul 29, 05
|
| 07:30 ET |
Advancis Pharmaceutical Announces Steps to Reduce Expenses
|
|
Jul 21, 05
|
| 19:00 ET |
Advancis Pharmaceutical Announces Results from Pediatric Amoxicillin PULSYS Phase III Trial
|
|
Jun 15, 05
|
| 19:00 ET |
Advancis Pharmaceutical Announces Results From Adult/Adolescent Amoxicillin PULSYS Phase III Trial
|
|
Jun 08, 05
|
| 07:30 ET |
Advancis Pharmaceutical Corporation Launches Keflex(R) Powder for Oral Suspension in the United States
|
|
May 17, 05
|
| 15:20 ET |
Advancis Pharmaceutical to Present at Upcoming Investor Conferences
|
|
May 09, 05
|
| 19:25 ET |
Advancis Pharmaceutical Closes Private Placement of Common Equity
|
|
Apr 29, 05
|
| 08:00 ET |
Advancis Pharmaceutical to Present at Rodman and Renshaw Global Healthcare Conference
|
|
Apr 27, 05
|
| 07:03 ET |
Advancis Pharmaceutical Reports First Quarter 2005 Results
|
|
Apr 26, 05
|
| 08:35 ET |
Advancis Pharmaceutical Raises $27 Million Through Private Placement of Common Equity
|
|
Apr 22, 05
|
| 07:00 ET |
Advancis Pharmaceutical Completes Enrollment in Pediatric Amoxicillin PULSYS Phase III Trial
|
|
Apr 19, 05
|
| 11:10 ET |
Advancis Pharmaceutical Signs Commercial Supply Agreement with Clonmel Healthcare
|
|
Apr 18, 05
|
| 16:15 ET |
Advancis Pharmaceutical to Announce First Quarter 2005 Financial Results on April 27, 2005
|
|
Mar 29, 05
|
| 07:43 ET |
Advancis Pharmaceutical Completes Enrollment in Adult/Adolescent Amoxicillin PULSYS Phase III Trial
|
|
Mar 22, 05
|
| 12:15 ET |
Advancis Pharmaceutical to Present at Lehman Brothers Global Healthcare Conference
|
|
Feb 10, 05
|
| 07:15 ET |
Advancis Pharmaceutical Reports Fourth Quarter and Full Year 2004 Results
|
|
Feb 01, 05
|
| 14:22 ET |
Advancis Pharmaceutical to Announce Fourth Quarter and Full Year 2004 Financial Results on February 10, 2005
|
|
Dec 17, 04
|
| 08:40 ET |
Advancis Pharmaceutical to Begin Pediatric Amoxicillin PULSYS Phase III Trial
|
|
Dec 14, 04
|
| 16:44 ET |
Advancis Pharmaceutical Modifies Amoxicillin PULSYS Agreement
|
|
Dec 13, 04
|
| 13:05 ET |
Study of Advancis Pharmaceutical's Pulsatile Dosing Published in Journal of Antimicrobial Chemotherapy
|
|
Dec 10, 04
|
| 07:00 ET |
Advancis Pharmaceutical to Conduct Scientific Update Conference Call on December 17, 2004
|
|
Dec 09, 04
|
| 15:47 ET |
Advancis Pharmaceutical Signs Commercial Supply Agreement With Ceph International
|
|
Nov 19, 04
|
| 07:00 ET |
Advancis Pharmaceutical Announces Steps to Reduce Spending and Prioritize Product Pipeline
|
|
Nov 02, 04
|
| 07:00 ET |
Researchers Report on Increased Bactericidal Effect of Advancis Pharmaceutical's Pulsatile Dosing
|
|
Oct 21, 04
|
| 16:21 ET |
Advancis Pharmaceutical to Present at C.E. Unterberg, Towbin Specialty Pharmaceutical Conference
|
|
Oct 19, 04
|
| 09:43 ET |
Advancis Pharmaceutical Reports Third Quarter 2004 Results and Termination of GSK Collaboration
|
|
Oct 12, 04
|
| 09:17 ET |
Advancis Pharmaceutical to Announce Third Quarter Financial Results on October 21, 2004
|
|
Sep 23, 04
|
| 16:42 ET |
Advancis Pharmaceutical to Begin Inaugural PULSYS Phase III Trial
|
|
Sep 17, 04
|
| 09:04 ET |
Advancis Pharmaceutical Announces Appointment of Joseph J. Rogus as Senior Vice President of Technical Operations
|
|
Sep 09, 04
|
| 18:18 ET |
Advancis Pharmaceutical Corporation to Present at Bear Stearns 17th Annual Healthcare Conference
|
|
Sep 02, 04
|
| 08:00 ET |
Advancis Pharmaceutical Corporation to Present at Thomas Weisel Partners Healthcare Tailwinds 2004 Conference
|
|
Jul 29, 04
|
| 07:04 ET |
Advancis Pharmaceutical Reports Second Quarter 2004 Results
|
|
Jul 22, 04
|
| 11:38 ET |
Advancis Pharmaceutical to Announce Second Quarter Financial Results on July 29, 2004
|
|
Jul 01, 04
|
| 07:00 ET |
Advancis Pharmaceutical Acquires Keflex Brand From Lilly
|
|
Jun 17, 04
|
| 08:01 ET |
Advancis Pharmaceutical Announces Promotion of David J. Kudla, Jr. to Vice President of Quality Assurance
|
|
Jun 14, 04
|
| 12:11 ET |
Advancis' Steve Shallcross Named CFO of the Year at Greater Washington Technology CFO Awards
|
|
Jun 02, 04
|
| 09:03 ET |
Advancis Pharmaceutical, Par Pharmaceutical Finalize Amoxicillin PULSYS Agreement
|
|
May 24, 04
|
| 07:01 ET |
Researchers Give Early Insight Into Mechanism of Action for Advancis' Novel Biological Discovery
|
|
May 10, 04
|
| 11:44 ET |
Advancis Pharmaceutical Corporation to Present at Upcoming Investor Conferences
|
|
Apr 29, 04
|
| 07:03 ET |
Advancis Pharmaceutical Reports First Quarter 2004 Results
|
|
Apr 21, 04
|
| 07:04 ET |
Advancis Pharmaceutical to Announce First Quarter Financial Results on April 29, 2004
|
|
Apr 16, 04
|
| 07:00 ET |
Advancis Pharmaceutical Names CEO Dr. Edward Rudnic Chairman of the Board
|
|
Apr 08, 04
|
| 08:56 ET |
Advancis Pharmaceutical Names Dr. Barry Hafkin Chief Scientific Officer
|
|
Mar 02, 04
|
| 16:30 ET |
Advancis Pharmaceutical Announces Partner For Amoxicillin PULSYS Product Candidate
|
|
Mar 01, 04
|
| 08:03 ET |
Advancis Pharmaceutical Announces Promotion of Kevin S. Sly To Chief Business Officer
|
|
Feb 20, 04
|
| 16:40 ET |
Advancis Pharmaceutical Corporation to Present At Upcoming Investor Conferences
|
|
Feb 12, 04
|
| 07:30 ET |
Advancis Pharmaceutical Reports Fourth Quarter And Full Year 2003 Results
|
|
Feb 02, 04
|
| 16:42 ET |
Advancis Pharmaceutical to Announce Fourth Quarter and Full Year 2003 Financial Results on February 12, 2004
|
|
Jan 08, 04
|
| 07:30 ET |
Advancis Pharmaceutical Corporation Receives First Milestone Payment of $3.0 Million from Collaboration with GlaxoSmithKline
|
|
Jan 06, 04
|
| 07:30 ET |
Advancis Pharmaceutical Continues to Expand Patent Estate
|
|